Chronic disorder management platform Livongo Health has attracted Blue Cross Blue Shield of Massachusetts, Merck and Wanxiang America Corporation for its series C round.

US-based digital health company Livongo Health raised $44.5m on Tuesday in a series C round featuring pharmaceutical company Merck’s Global Health Innovation Fund and auto parts provider Wanxiang America Corporation.

Zaffre Investments, the corporate venturing unit of insurance company Blue Cross Blue Shield of Massachusetts, and Sapphire Ventures, the VC firm spun out of enterprise software producer SAP, also took part in the round.

The corporates were joined by Cowen Private Investments, General Catalyst, Kleiner Perkins Caufield & Byers (KPCB),…